Multitargeted therapy of cancer by ellagitannins.

Ellagitannins are bioactive polyphenols that have antioxidant and anti-inflammatory bioactivities. Pomegranate juice has the highest concentration of ellagitannins of any commonly consumed juice and contains the unique ellagitannin, punicalagin. Punicalagin is the largest molecular weight polyphenol known. Ellagitannins are not absorbed intact into the blood stream but are hydrolyzed to ellagic acid. They are also metabolized by gut flora into urolithins which are conjugated in the liver and excreted in the urine. These urolithins are also bioactive and inhibit prostate cancer cell growth. Inhibition of Nuclear Factor Kappa-B activation has been shown in prostate cancer cells and in human prostate cancer xenografts in mice. In clinical studies, pomegranate juice administration led to a decrease in the rate of rise of Prostate Specific Antigen after primary treatment with surgery or radiation. Continued translational research on the chemopreventive potential of pomegranate ellagitannins is ongoing.

[1]  Debajit K. Biswas,et al.  Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells , 2000 .

[2]  W. Zong,et al.  Mechanisms of constitutive NF‐κB activation in human prostate cancer cells , 2002, The Prostate.

[3]  David Heber,et al.  Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. , 2006, The Journal of nutrition.

[4]  David Heber,et al.  Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Mansel,et al.  Pomegranate Extracts Potently Suppress Proliferation, Xenograft Growth, and Invasion of Human Prostate Cancer Cells , 2004 .

[6]  Y. Amakura,et al.  High-performance liquid chromatographic determination with photodiode array detection of ellagic acid in fresh and processed fruits. , 2000, Journal of chromatography. A.

[7]  J. Espín,et al.  The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. , 2006, The Journal of nutritional biochemistry.

[8]  E. Campo,et al.  Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse , 2005, British Journal of Cancer.

[9]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[10]  M. Willingham,et al.  p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. , 1999, Cancer letters.

[11]  Marc A Suchard,et al.  Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. , 2007, Journal of agricultural and food chemistry.

[12]  K J O'Byrne,et al.  Chronic immune activation and inflammation as the cause of malignancy , 2001, British Journal of Cancer.

[13]  N. Seeram,et al.  Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States. , 2008, Journal of agricultural and food chemistry.

[14]  B. Cerdá,et al.  The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy–6H–dibenzopyran–6– one derivatives by the colonic microflora of healthy humans , 2004, European journal of nutrition.

[15]  R. Elashoff,et al.  Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer , 2006, Clinical Cancer Research.

[16]  P. Froom,et al.  Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions , 2004, Investigational New Drugs.

[17]  W. Isaacs,et al.  Human prostate cancer precursors and pathobiology. , 2003, Urology.

[18]  B. Cerdá,et al.  Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. , 2007, Journal of agricultural and food chemistry.

[19]  N. Seeram,et al.  Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. , 2006, Journal of agricultural and food chemistry.

[20]  H. Bawadi,et al.  In vitro anti-proliferative activities of ellagic acid. , 2004, The Journal of nutritional biochemistry.

[21]  H. Mukhtar,et al.  Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 mice , 2005, International journal of cancer.

[22]  D. Blake,et al.  Antioxidants, redox-regulated transcription factors, and inflammation. , 1997, Advances in pharmacology.

[23]  Hasan Mukhtar,et al.  Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer , 2005 .

[24]  E. Conner,et al.  Inflammation, free radicals, and antioxidants. , 1996, Nutrition.

[25]  C. N. Coleman,et al.  Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen , 1999, Oncogene.

[26]  A. Baldwin.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.

[27]  F. Tomás-Barberán,et al.  Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. , 2000, Journal of agricultural and food chemistry.

[28]  B. Cerdá,et al.  Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice , 2003, European journal of nutrition.

[29]  N. Seeram,et al.  Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. , 2008, International journal of oncology.

[30]  David Heber,et al.  Pomegranates : Ancient Roots to Modern Medicine , 2006 .

[31]  R. Longtin.  The pomegranate: nature's power fruit? , 2003, Journal of the National Cancer Institute.

[32]  M. Boukharta,et al.  Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligomeric anthocyanin and procyanidin. , 1997, International journal of oncology.

[33]  M. Mayo,et al.  The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. , 2000, Biochimica et biophysica acta.

[34]  Fred Saad,et al.  Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer , 2004, Clinical Cancer Research.

[35]  David Heber,et al.  In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. , 2005, The Journal of nutritional biochemistry.

[36]  A. Scalbert,et al.  Ellagitannins : nature, occurrence and dietary burden , 2000 .

[37]  A. Allison.  Antioxidant drug targeting. , 1997, Advances in pharmacology.

[38]  J. Russo,et al.  Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. , 2000, Carcinogenesis.